(S)-N-(2-Chloro-3-(2-imino-4-methyl-6-oxo-1-(tetrahydro-2H-pyran-4-yl)hexahydropyrimidin-4-yl)phenyl)benzamide

ID: ALA5204856

Chembl Id: CHEMBL5204856

PubChem CID: 156104171

Max Phase: Preclinical

Molecular Formula: C23H25ClN4O3

Molecular Weight: 440.93

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@]1(c2cccc(NC(=O)c3ccccc3)c2Cl)CC(=O)N(C2CCOCC2)C(=N)N1

Standard InChI:  InChI=1S/C23H25ClN4O3/c1-23(14-19(29)28(22(25)27-23)16-10-12-31-13-11-16)17-8-5-9-18(20(17)24)26-21(30)15-6-3-2-4-7-15/h2-9,16H,10-14H2,1H3,(H2,25,27)(H,26,30)/t23-/m0/s1

Standard InChI Key:  XLTGKSSWCQBJHD-QHCPKHFHSA-N

Alternative Forms

  1. Parent:

    ALA5204856

    ---

Associated Targets(Human)

CTSD Tchem Cathepsin D (3201 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PMX Plasmepsin X (23 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 440.93Molecular Weight (Monoisotopic): 440.1615AlogP: 3.74#Rotatable Bonds: 4
Polar Surface Area: 94.52Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.07CX LogP: 2.86CX LogD: 2.85
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.67Np Likeness Score: -0.68

References

1. Lowe MA, Cardenas A, Valentin JP, Zhu Z, Abendroth J, Castro JL, Class R, Delaunois A, Fleurance R, Gerets H, Gryshkova V, King L, Lorimer DD, MacCoss M, Rowley JH, Rosseels ML, Royer L, Taylor RD, Wong M, Zaccheo O, Chavan VP, Ghule GA, Tapkir BK, Burrows JN, Duffey M, Rottmann M, Wittlin S, Angulo-Barturen I, Jiménez-Díaz MB, Striepen J, Fairhurst KJ, Yeo T, Fidock DA, Cowman AF, Favuzza P, Crespo-Fernandez B, Gamo FJ, Goldberg DE, Soldati-Favre D, Laleu B, de Haro T..  (2022)  Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362.,  65  (20.0): [PMID:36216349] [10.1021/acs.jmedchem.2c01336]

Source